Stay tuned for live coverage from the American Society of Interventional Pain Physicians (ASIPP) 2012 Annual Meeting.
Proactively addressing potential opioid-related side effects and knowing the factors that can affect how opioids are metabolized can lead to more effective treatment.
Properties that enable applications in both pain management and addiction medicine make buprenorphine unique among opioids.
Andrea M. Trescot, MD, Clay Surgery and Pain Center, Orange Park, FL, discusses opioid therapy side effects.
David Schultz, MD, Director-at-Large, American Society of Interventional Pain Physicians, Medical Advanced Pain Specialists, Minneapolis, MN, discusses single dose vials and government regulation.
These studies were among those selected for special recognition at the 2012 annual meeting of the American Society of Interventional Pain Physicians (ASIPP).
Judith Holmes, JD, Judith Holmes & Associates, LLC, Golden, CO, discusses employment law for physicians.
Sukdeb Datta, MD, Laser Spine & Pain Institute, New York, NY, discusses key issues in pain management.
Sanford Silverman, MD, Comprehensive Pain Medicine, Pompano Beach, FL, discusses buprenorphine.
These studies were among those selected for special recognition at the 2012 annual meeting of the American Society of Interventional Pain Physicians (ASIPP).
Several Senators and Representatives call the current regulations wasteful and poorly conceived, and say they will work to make needed changes.
Sukdeb Datta, MD, Laser Spine & Pain Institute, New York, NY, discusses the future of interventional pain management.
